Stock Investors Bid Up Shares of Sanofi-Aventis, Up 2.1%

The government signed a strategic partnership agreement with the Hungarian unit of French drugmaker Sanofi on Tuesday. The agreement was signed by state secretary for foreign affairs and external economic relations Péter Szijjártó and Sanofi ...

CHICAGO (Photo: http://photos.prnewswire.com/prnh/20120712/CG39046) To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch Alerts at http://www.investorsobserver.com/pr/52120131 (Note: You may have to ...

An experimental drug being developed by Regeneron Pharmaceuticals Inc. and Sanofi SA showed promising results during a small, mid-stage clinical trial in treating a subset of patients with moderate to severe asthma, but some physicians cautioned ...

By | More Articles This morning, positive results from a phase 2a study testing an experimental asthma drug developed by biotech Regeneron (NASDAQ: REGN While investors have made huge gains with Regeneron in the past 12 months, this is one of many ...

Sanofi has announced that Peter Guenter, currently senior vice president, Europe, Sanofi, will be appointed executive vice president, global commercial operations and Pascale Witz, currently president and CEO of medical diagnostics at GE Healthcare, ...

With theSPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies that ...

This report provides all the information you require to better understand Sanofi and its partnering interests and activities over the past seven years.One of the key aspects of partnering is finding those companies that are potential partners for ...

Sanofi (SAN) won a U.S. appeals court ruling yesterday that revives a patent-infringement claim over generic versions of the allergy drug Allegra. A trial judge erred in interpreting a patent on the drug that covers a process to make the active ...